IMR Press / CEOG / Volume 11 / Issue 1-2 / pii/1634257802476-2141700382

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Repetitive debulking surgery as adjuv ant to chemotherapy in adv an ced epithelial ovarian cancer
Show Less
1 Institute of Obstetrics and Gynecology University of Padua (Italy)
Clin. Exp. Obstet. Gynecol. 1984, 11(1-2), 21–26;
Published: 10 March 1984
Abstract

The Authors refer their own experience on a planned prospective study of integrated chemosurgical treatment in advanced epithelial ovarian cancer. Repetitive surgery interspersed with non cross resistant schedules of chemotherapy can achieve more than 60% of complete responses with an expected five years survival rate dependent on the residual disease after primary and especially second operation. In particular residual neoplasia larger than five centimeters after the first laparotomy or larger than two centimeters left behind at second laparotomy constitutes the worst prognostic index.
Share
Back to top